STRM — Streamline Health Solutions Income Statement
0.000.00%
- $11.58m
- $23.09m
- $22.60m
- 26
- 70
- 18
- 31
Annual income statement for Streamline Health Solutions, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
R2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.9 | 11.3 | 17.4 | 24.9 | 22.6 |
Cost of Revenue | |||||
Gross Profit | 6.5 | 5.66 | 8.8 | 11.5 | 11.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 19.2 | 17.3 | 25.9 | 35.7 | 42.2 |
Operating Profit | -7.35 | -5.95 | -8.48 | -10.8 | -19.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.88 | -6.06 | -6.81 | -11.3 | -18.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.24 | -4.8 | -6.92 | -11.4 | -18.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.86 | 0.296 | -6.54 | -11.4 | -18.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.03 | 0.296 | -6.54 | -11.4 | -18.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.223 | -2.39 | -2.29 | -3.47 | -2.91 |